{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:40:50Z","timestamp":1793108450912,"version":"4.5.0"},"reference-count":46,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"11","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2021,9,14]]},"DOI":"10.1167\/tvst.10.11.14","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T16:30:53Z","timestamp":1631637053000},"page":"14","source":"Crossref","is-referenced-by-count":11,"title":["In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models"],"prefix":"10.1167","volume":"10","author":[{"given":"Yi-Yong","family":"Baek","sequence":"first","affiliation":[{"name":"Avixgen Inc., Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokyung","family":"Sung","sequence":"additional","affiliation":[{"name":"Avixgen Inc., Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Sub","family":"Choi","sequence":"additional","affiliation":[{"name":"Avixgen Inc., Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Kyu","family":"Go","sequence":"additional","affiliation":[{"name":"KNOTUS Co. Ltd., Incheon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Hyung","family":"Kim","sequence":"additional","affiliation":[{"name":"KNOTUS Co. Ltd., Incheon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Young","family":"Hyon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Chang","family":"You","sequence":"additional","affiliation":[{"name":"Avixgen Inc., Seoul, Republic of Korea"},{"name":"National Research Laboratory for Molecular Virology, Department of Pathology, School of Medicine, The Catholic University of Korea, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"3","key":"bib1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"bib2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12886-019-1290-z","article-title":"Prevalence and associated risk factors of dry eye disease in 16 northern West Bank towns in Palestine: a cross-sectional study","volume":"20","author":"Shanti","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1476-072X-13-31","article-title":"Spatial epidemiology of dry eye disease: findings from South Korea","volume":"13","author":"Um","year":"2014","journal-title":"Int J Health Geogr"},{"issue":"3","key":"bib4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"issue":"6","key":"bib5","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.1111\/aos.2014.92.issue-6","article-title":"Dry eye disease in French elderly subjects: the Alienor Study","volume":"92","author":"Malet","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S5555","article-title":"Etiology, prevalence, and treatment of dry eye disease","volume":"3","author":"Gayton","year":"2009","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"bib7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","article-title":"The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","author":"Epidemiology DEWS Subcommittee","year":"2007","journal-title":"Ocul Surf"},{"issue":"2-3","key":"bib8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"issue":"2","key":"bib9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","article-title":"Lifitegrast, a novel integrin antagonist for treatment of dry eye disease","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul Surf"},{"issue":"3","key":"bib10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II Management and Therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"6","key":"bib11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/ICO.0000000000000803","article-title":"Safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease: a 1-year, multicenter, randomized, placebo-controlled study","volume":"35","author":"Donnenfeld","year":"2016","journal-title":"Cornea"},{"key":"bib12","first-page":"357027","article-title":"Imatinib: a breakthrough of targeted therapy in cancer","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Chemother Res Pract"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejca.2020.09.014","article-title":"Repurposing anticancer drugs for the management of COVID-19","volume":"141","author":"El Bairi","year":"2020","journal-title":"Eur J Cancer"},{"issue":"5","key":"bib14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/07853890310001339","article-title":"Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases","volume":"35","author":"Eklund","year":"2003","journal-title":"Ann Med"},{"issue":"5","key":"bib15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/ATVBAHA.115.305085","article-title":"Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome","volume":"35","author":"Rizzo","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"bib16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/joim.12576","article-title":"Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis","volume":"281","author":"Wahlgren","year":"2017","journal-title":"J Intern Med"},{"issue":"3","key":"bib17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/1872213X113079990021","article-title":"Imatinib mesylate: an innovation in treatment of autoimmune diseases","volume":"7","author":"Azizi","year":"2013","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"1","key":"bib18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1006\/exer.2000.0932","article-title":"Discoidin domain receptor (DDR) 1 and 2: collagen-activated tyrosine kinase receptors in the cornea","volume":"72","author":"Mohan","year":"2001","journal-title":"Exp Eye Res"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.matbio.2013.12.002","article-title":"Discoidin domain receptors in disease","volume":"34","author":"Borza","year":"2014","journal-title":"Matrix Biol"},{"issue":"8","key":"bib20","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1021\/jm5012319","article-title":"Small molecule discoidin domain receptor kinase inhibitors and potential medical applications","volume":"58","author":"Li","year":"2015","journal-title":"J Med Chem"},{"issue":"3","key":"bib21","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1167\/iovs.17-23479","article-title":"Narrow spectrum kinase inhibitors demonstrate promise for the treatment of dry eye disease and other ocular inflammatory disorders","volume":"59","author":"Hagan","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"bib22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5935\/0004-2749.20150078","article-title":"Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits","volume":"78","author":"Parrilha","year":"2015","journal-title":"Arq Bras Oftalmol"},{"issue":"6","key":"bib23","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S0161-6420(85)33967-2","article-title":"Staging of conjunctival squamous metaplasia by impression cytology","volume":"92","author":"Tseng","year":"1985","journal-title":"Ophthalmology"},{"issue":"3","key":"bib24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000055537","article-title":"Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes","volume":"31","author":"Burgalassi","year":"1999","journal-title":"Ophthalmic Res"},{"issue":"6","key":"bib25","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1167\/iovs.03-1055","article-title":"Animal models of dry eye: a critical assessment of opportunities and limitations","volume":"45","author":"Barabino","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"bib26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00004397-198702710-00003","article-title":"Clinical diagnosis of the dry eye","volume":"27","author":"Whitcher","year":"1987","journal-title":"Int Ophthalmol Clin"},{"issue":"4","key":"bib27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"bib28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/02713683.2013.842592","article-title":"In vivo confocal microscopy of the ocular surface: from bench to bedside","volume":"39","author":"Villani","year":"2014","journal-title":"Curr Eye Res"},{"issue":"5","key":"bib29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/ACI.0b013e328364ec92","article-title":"In-vivo confocal microscopy of the ocular surface: ocular allergy and dry eye","volume":"13","author":"Villani","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/B978-0-12-800180-6.00002-5","article-title":"Discoidin domain receptor functions in physiological and pathological conditions","volume":"310","author":"Leitinger","year":"2014","journal-title":"Int Rev Cell Mol Biol"},{"issue":"14","key":"bib31","doi-asserted-by":"publisher","first-page":"DES192","DOI":"10.1167\/iovs.17-23651","article-title":"Inflammatory response in dry eye","volume":"59","author":"Yamaguchi","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"bib32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/ACI.0000000000000098","article-title":"Conjunctival epithelial and goblet cell function in chronic inflammation and ocular allergic inflammation","volume":"14","author":"Dartt","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"bib33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000150445","article-title":"Inflammatory markers in the tears of patients with ocular surface disease","volume":"40","author":"Acera","year":"2008","journal-title":"Ophthalmic Res"},{"issue":"38","key":"bib34","doi-asserted-by":"publisher","first-page":"13622","DOI":"10.1073\/pnas.0501758102","article-title":"The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation","volume":"102","author":"Wolf","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"bib35","doi-asserted-by":"publisher","first-page":"G907","DOI":"10.1152\/ajpgi.00420.2004","article-title":"Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats","volume":"288","author":"Yoshiji","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"bib36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/cvr\/cvn063","article-title":"Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis","volume":"79","author":"Leipner","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"3","key":"bib37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/s10165-010-0392-5","article-title":"Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis","volume":"21","author":"Akashi","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"1\u20133","key":"bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2008.10.014","article-title":"Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib","volume":"599","author":"Day","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"32","key":"bib39","doi-asserted-by":"publisher","first-page":"22744","DOI":"10.1074\/jbc.M603233200","article-title":"A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1","volume":"281","author":"Noordeen","year":"2006","journal-title":"J Biol Chem"},{"issue":"18","key":"bib40","doi-asserted-by":"publisher","first-page":"12026","DOI":"10.1074\/jbc.M704592200","article-title":"Identification of disulfide-linked dimers of the receptor tyrosine kinase DDR1","volume":"283","author":"Abdulhussein","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"bib41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","article-title":"Mechanisms of receptor tyrosine kinase activation in cancer","volume":"17","author":"Du","year":"2018","journal-title":"Mol Cancer"},{"issue":"6","key":"bib42","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/emboj\/cdg129","article-title":"p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop","volume":"22","author":"Ongusaha","year":"2003","journal-title":"EMBO J"},{"issue":"15","key":"bib43","doi-asserted-by":"publisher","first-page":"12912","DOI":"10.1074\/jbc.M110.143693","article-title":"Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1\/2-mediated mechanism in primary human lung fibroblasts","volume":"286","author":"Ruiz","year":"2011","journal-title":"J Biol Chem"},{"issue":"2","key":"bib44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1188\/16.ONF.235-243","article-title":"Ocular toxicity of tyrosine kinase inhibitors","volume":"43","author":"Davis","year":"2016","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"bib45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/ejb.1970.17.issue-3","article-title":"Phosphodeoxyribomutase from Escherichia Coli. Purification and some properties","volume":"17","author":"Hammer-Jespersen","year":"1970","journal-title":"Eur J Biochem"},{"issue":"3","key":"bib46","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fsb2.v22.3","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2777900","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T16:30:58Z","timestamp":1631637058000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2777900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.10.11.14","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,14]]}}}